![Frontiers | Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease Frontiers | Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease](https://www.frontiersin.org/files/MyHome%20Article%20Library/632131/632131_Thumb_400.jpg)
Frontiers | Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease
![2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | Circulation 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | Circulation](https://www.ahajournals.org/cms/asset/e8a43f02-0e6a-424b-8128-8795dbbf8b21/2440fig10.jpg)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | Circulation
Investigation of Sialylation Aberration in N-linked Glycopeptides By Lectin and Tandem Labeling (LTL) Quantitative Proteomics | Analytical Chemistry
![Supplier-origin mouse microbiomes significantly influence locomotor and anxiety-related behavior, body morphology, and metabolism | Communications Biology Supplier-origin mouse microbiomes significantly influence locomotor and anxiety-related behavior, body morphology, and metabolism | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-021-02249-0/MediaObjects/42003_2021_2249_Fig1_HTML.png)
Supplier-origin mouse microbiomes significantly influence locomotor and anxiety-related behavior, body morphology, and metabolism | Communications Biology
![JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease](https://pub.mdpi-res.com/jcdd/jcdd-09-00437/article_deploy/html/images/jcdd-09-00437-g003.png?1670308497)
JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease
![JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease](https://pub.mdpi-res.com/jcdd/jcdd-09-00437/article_deploy/html/images/jcdd-09-00437-g002.png?1670308499)
JCDD | Free Full-Text | Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease
![Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells | American Journal of Physiology-Renal Physiology Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells | American Journal of Physiology-Renal Physiology](https://journals.physiology.org/cms/10.1152/ajprenal.00365.2021/asset/images/medium/f-00365-2021r01.png)
Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells | American Journal of Physiology-Renal Physiology
![Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/b9f5725d-ef4e-497b-9b2f-f30b02e6dc7a/e004395fig05.jpeg)